🚀 Over the past few years, the Chinese mainland has soared in drug discovery, now standing as the second-largest hub for new drug research worldwide.
According to the Chinese National Health Commission (NHC), more than 20% of new drugs in development globally are currently being researched on the Chinese mainland. This surge highlights the region’s growing influence in biotech and pharmaceutical innovation.
A wave of domestically developed drugs—including cutting-edge anti-cancer medications—has recently received market approval. Guo Yanhong, deputy head of the NHC, highlighted at a press conference on the Chinese mainland’s healthcare progress from 2021 to 2025 that these breakthroughs fill previous gaps in the homegrown drug portfolio.
For young professionals, students, and investors tracking global health trends, this boom offers fresh opportunities. From market launches to research partnerships, the Chinese mainland’s rise signals a vibrant future for the pharmaceutical industry both in Asia and beyond. 💉🔬
Reference(s):
cgtn.com
